Sipuleucel-T
Sipuleucel-T is a cancer vaccine. Sipuleucel-T recognizes prostatic acid phosphatase (PAP), present PAP antigens, and stimulates the immune response against prostate cancer cells[1].
Product Specifications
CAS Number
917381-47-6
UNSPSC
12352100
Target
Phosphatase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sipuleucel-t.html
Smiles
[Sipuleucel-T]
References & Citations
[1]Handy CE, et al., Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions. Future Oncol. 2018 Apr;14 (10) :907-917. doi: 10.2217/fon-2017-0531. Epub 2017 Dec 20.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog